Pfizer's COVID-19 vaccine shows long-term efficacy in adolescents

Pfizer said on Monday that its COVID-19 vaccine provided strong long-term protection against the coronavirus in a late-stage study conducted among adolescents ages 12 to 15.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting